000 | 01092 a2200301 4500 | ||
---|---|---|---|
005 | 20250517073244.0 | ||
264 | 0 | _c20161104 | |
008 | 201611s 0 0 eng d | ||
022 | _a1872-8294 | ||
024 | 7 |
_a10.1016/j.addr.2015.12.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVandooren, Jennifer | |
245 | 0 | 0 |
_aProteases in cancer drug delivery. _h[electronic resource] |
260 |
_bAdvanced drug delivery reviews _cFeb 2016 |
||
300 |
_a144-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPeptide Hydrolases _xmetabolism |
650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
700 | 1 | _aOpdenakker, Ghislain | |
700 | 1 | _aLoadman, Paul M | |
700 | 1 | _aEdwards, Dylan R | |
773 | 0 |
_tAdvanced drug delivery reviews _gvol. 97 _gp. 144-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.addr.2015.12.020 _zAvailable from publisher's website |
999 |
_c25621732 _d25621732 |